Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema.
Sección de Alergia, Hospital Universitario Central de Asturias, Oviedo, Spain. Electronic address: julian.azofra@sespa.princast.es.
Julián
J
Azofra
Sección de Alergia, Hospital Universitario Central de Asturias, Oviedo, Spain.
Carmen
C
Díaz
Servicio de Alergia, Hospital de Basurto, Bilbao, Spain.
Ignacio
I
Antépara
Servicio de Alergia, Hospital de Basurto, Bilbao, Spain.
Ignacio
I
Jaúregui
Servicio de Alergia, Hospital de Basurto, Bilbao, Spain.
Ana
A
Soriano
Departamento de Alergia, Clínica Universitaria de Navarra, Pamplona, Spain.
Marta
M
Ferrer
D000328:Adult; D000368:Aged; D000799:Angioedema / Q000188:drug therapy*; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab